Copyright
©The Author(s) 2021.
World J Clin Cases. Feb 26, 2021; 9(6): 1293-1303
Published online Feb 26, 2021. doi: 10.12998/wjcc.v9.i6.1293
Published online Feb 26, 2021. doi: 10.12998/wjcc.v9.i6.1293
Table 2 Incidences of cardiovascular events during anesthesia
| Propofol group (n = 40) | Etomidate group (n = 40) | P value | |
| Bradycardia, n (%) | 11 (27.5%) | 3 (7.5%) | 0.037 |
| Tachycardia, n (%) | 1 (2.5%) | 3 (7.5%) | 0.615 |
| Hypotension, n (%) | 17 (42.5%) | 4 (10.0%) | 0.027 |
| ST-T segment changes, n (%) | 8 (20.0%) | 2 (5.0%) | 0.029 |
| Ventricular premature beats, n (%) | 11 (27.5%) | 3 (7.5%) | 0.041 |
- Citation: Dai ZL, Cai XT, Gao WL, Lin M, Lin J, Jiang YX, Jiang X. Etomidate vs propofol in coronary heart disease patients undergoing major noncardiac surgery: A randomized clinical trial. World J Clin Cases 2021; 9(6): 1293-1303
- URL: https://www.wjgnet.com/2307-8960/full/v9/i6/1293.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v9.i6.1293